Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
113100
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of warrants with exercise price adjustment clauses (monthly report)
発行・処分する株式数
113,100 new shares (during October 2026)
発行済株式総数
0.32% (exercise ratio under the exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices in October 2026 included ¥197.88 and ¥190.00. The terms provide for adjustments based on the share price. Floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 86,000 rights; exercised during the month: 1,131; unexercised at month-end: 36,135
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Series 25 stock acquisition rights issued on 8 December 2025 (with an exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of warrants with exercise price adjustment clauses (monthly report) |
| Number of shares to be issued or disposed of | 113,100 new shares (during October 2026) |
| Dilution Rate | 0.32% (exercise ratio under the exercise restrictions) |
| Exercise price | Exercise prices in October 2026 included ¥197.88 and ¥190.00. The terms provide for adjustments based on the share price. Floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 86,000 rights; exercised during the month: 1,131; unexercised at month-end: 36,135 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Series 25 stock acquisition rights issued on 8 December 2025 (with an exercise price adjustment clause) |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company states that this is to report exercise activity for October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.